Kailera Therapeutics, Inc. Common Stock (KLRA)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Market Cap
- $1.8B
About Kailera Therapeutics, Inc. Common Stock
Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.
SentiSense also tracks daily options readings for Kailera Therapeutics, Inc. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Kailera Therapeutics, Inc. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.